In this study, significant hair loss was found to be less common among white male CEOs aged 50-69 years than in the general white male population.
January 2021 in “Skinmed” This study found that significant hair loss among white male CEOs aged 50-69 years occurred less frequently than previously reported for the general white male population.
This study found that sericin dressing containing collagen hydrolysate significantly reduced wound healing time and improved scar quality compared to commercial dressing in split-thickness skin graft donor sites.
August 2020 in “The American Journal of Cosmetic Surgery” This study found that hair transplant surgery significantly reduced anxiety scores in bald patients over an average period of 12.7 months.
August 2020 in “Universidad Peruana de Ciencias Aplicadas (UPC)” This study found that platelet-rich plasma appeared more effective than control treatments as an additional therapy for improving acne scars in several clinical trials.
January 2020 in “Przegla̧d dermatologiczny” This article presents a clinical approach to diagnosing and managing hirsutism from a dermatological perspective, but it reports no new clinical findings.
January 2020 in “프로그램북(구 초록집)” This study found that using a low-level light therapy helmet device daily for 24 weeks improved hair density and thickness among participants, though it did not significantly impact sebum secretion or erythema index.
June 2019 in “Journal of Dermatological Treatment” This study reported that a novel filler, BM-PHA, demonstrated similar efficacy and safety to Restylane Perlane in treating moderate to severe nasolabial folds over 24 weeks, showing only minor local side effects and similar improvements in wrinkle severity scores between the two treatments.
January 2019 in “Research Square (Research Square)” In this study, researchers will conduct a randomized, double-blind, multi-center clinical trial to assess the effectiveness of YH0618 granule in preventing chemotherapy-induced hair loss among breast cancer patients, aiming to understand its mechanism related to kidney deficiency in Chinese Medicine. Results are not yet reported.
November 2018 in “Annals of oncology” This study found that the computer-controlled RV-01 scalp cooling device helped prevent significant hair loss in metastatic breast cancer patients treated with eribulin, with none of the 16 patients requiring a wig and experiencing minimal discomfort.
January 2018 in “Turkiye Klinikleri Journal of Medical Sciences” This study observed that while alopecia treatment in patients showed some improvements in quality of life and anxiety scores at six months, these changes were not statistically significant.
January 2018 in “프로그램북(구 초록집)” In this study, intradermal injection of botulinum toxin type A significantly increased hair count and improved physician-assessed hair condition in men with male pattern baldness after 24 weeks, with no serious adverse events reported beyond temporary local pain and redness.
August 2017 in “International journal of research in dermatology” This study found that topical 0.05% betamethasone dipropionate was the most effective treatment for patients with patchy alopecia areata, with less than 25% hair loss, over a 12-week period, compared to other topical treatments.
In this study conducted among high school students in rural Eskişehir, Turkey, alopecia prevalence was 37.4% and was associated with factors such as oily scalp and irregular menstruation, negatively affecting quality of life.
January 2015 in “Iraqi Journal of Hematology” In this study, oral iron replacement therapy showed improvement in hair loss severity for some women with low serum ferritin levels, but not all responded.
This study found that low-level laser therapy significantly improved hair count and reduced hair loss in patients with alopecia areata of the scalp.
October 2013 in “Journal of the American College of Cardiology” This study investigates the potential link between atrial fibrillation and circulating aldosterone levels related to cardiac fibrosis in patients with hypertension.
January 2013 in “Journal of Practical Dermatology” This study found a strong correlation between hair loss conditions, particularly alopecia areata, and poor sleep quality and anxiety, particularly affecting younger populations and females.
January 2012 in “Yearbook of Dermatology and Dermatologic Surgery” Electric current quickly reduces hand sweating but the effect doesn't last long.
July 2010 in “学術講演梗概集. A-1, 材料施工” This study found that in Taiwanese men with androgenetic alopecia, finasteride 1 mg/day over 1 year slowed hair loss and promoted hair growth, with minimal adverse effects.
January 2009 in “Yearbook of Dermatology and Dermatologic Surgery” Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.
January 2003 in “Zhongguo linchuang jiepouxue zazhi” In this rat study, HHK implantation after spinal cord injury did not significantly improve locomotion but may have integrated into the spinal tissue, potentially aiding recovery and reconstruction.
This study found that spironolactone reduced hirsutism scores in women without significant hormonal changes, suggesting its effectiveness primarily through peripheral mechanisms.
March 2023 in “Civil Medical Journal” This observational study found that 37% of male patients with androgenetic alopecia had a history of preceding COVID-19 infection, suggesting a potential link between the two.
March 2023 in “Pakistan Journal of Medical and Health Sciences” This study found that premenopausal women with female-pattern hair loss had significantly lower serum vitamin D levels compared to healthy controls, suggesting a potential role of vitamin D deficiency in this condition.
March 2023 in “Journal of Cosmetic Dermatology” This study found that hair transplant surgery significantly improved self-esteem and quality of life in patients with androgenetic alopecia.
January 2023 in “Dermatologic Therapy” This study demonstrates a significant correlation between anxiety, depression, and reduced quality of life in individuals with androgenetic alopecia.
December 2022 in “PubMed” This study observed that one-third of men with early-onset androgenetic alopecia had altered hormonal profiles, which were associated with increased insulin resistance and more severe hair loss.
November 2022 in “Hair transplant forum international” In this study, finasteride use in men with androgenetic alopecia was not associated with increased reports of sexual dysfunction compared to non-users, suggesting that finasteride does not cause sexual dysfunction in this context.
April 2022 in “Journal of the Medical Sciences” This study found a significant relationship between the severity of androgenetic alopecia in men and a negative impact on their quality of life.